5KYJ image
Entry Detail
PDB ID:
5KYJ
Keywords:
DNA BINDING PROTEIN
Title:
Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core
Biological Source:
Source Organism:
Homo sapiens
Host Organism:
Escherichia coli
PDB Version:
Deposition Date:
2016-07-21
Release Date:
2016-09-21
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.80 Å
R-Value Free:
0.25
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 21 21 21
5KYJ validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Description:Oxysterols receptor LXR-beta
Mutations:G213H, E214M, Q259A, R261G, D262S, R264S
Chain IDs:A, C (auth: E)
Chain Length:287
Number of Molecules:2
Biological Source:Homo sapiens
UniProt ID:P55055 Pfam ID:PF00104
Protein Blast
Polymer Type:polypeptide(L)
Description:Retinoic acid receptor RXR-beta
Mutations:G293M
Chain IDs:B, D (auth: F)
Chain Length:256
Number of Molecules:2
Biological Source:Homo sapiens
UniProt ID:P28702 Pfam ID:PF00104
Ligand Molecules
6Y8
Primary Citation
Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core.
Bioorg.Med.Chem.Lett. 26 5044 5050 (2016)
PMID: 27599745 DOI: 10.1016/j.bmcl.2016.08.089

Abstact

Liver X receptor (LXR) agonists have been reported to lower brain amyloid beta (Aβ) and thus to have potential for the treatment of Alzheimer's disease. Structure and property based design led to the discovery of a series of orally bioavailable, brain penetrant LXR agonists. Oral administration of compound 18 to rats resulted in significant upregulation of the expression of the LXR target gene ABCA1 in brain tissue, but no significant effect on Aβ levels was detected.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
5I4V
5KYA